NASP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.311170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.142150E-01
Normal-vs-Stage2
1.584790E-01
Normal-vs-Stage3
1.564170E-01
Normal-vs-Stage4
3.645000E-01
Stage1-vs-Stage2
3.219200E-01
Stage1-vs-Stage3
6.706600E-01
Stage1-vs-Stage4
2.695800E-01
Stage2-vs-Stage3
2.014800E-01
Stage2-vs-Stage4
8.473400E-01
Stage3-vs-Stage4
2.243800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.459640E-01
Normal-vs-AfricanAmerican
3.585200E-01
Normal-vs-Asian
1.476010E-01
Caucasian-vs-AfricanAmerican
9.029400E-01
Caucasian-vs-Asian
8.469800E-01
AfricanAmerican-vs-Asian
9.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.406000E-02
Normal-vs-Female
3.005600E-01
Male-vs-Female
2.439900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.984800E-01
Normal-vs-Age(41-60Yrs)
3.018600E-01
Normal-vs-Age(61-80Yrs)
8.551600E-02
Normal-vs-Age(81-100Yrs)
2.333600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.464800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.566000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.929400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.517200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.714800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.944800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.794830E-01
Normal-vs-Daily Drinker
2.131200E-01
Normal-vs-Weekly Drinker
4.595200E-01
Normal-vs-Occasional Drinker
1.193200E-01
Normal-vs-Social Drinker
1.916370E-01
Non Drinker-vs-Daily Drinker
5.974400E-01
Non Drinker-vs-Weekly Drinker
4.546400E-01
Non Drinker-vs-Occasional Drinker
5.272200E-01
Non Drinker-vs-Social Drinker
5.692200E-01
Daily Drinker-vs-Weekly Drinker
7.265400E-01
Daily Drinker-vs-Occasional Drinker
9.771200E-01
Daily Drinker-vs-Social Drinker
9.260600E-01
Weekly Drinker-vs-Occasional Drinker
7.491200E-01
Weekly Drinker-vs-Social Drinker
7.939200E-01
Occasional Drinker-vs-Social Drinker
9.366800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.368400E-01
Normal-vs-Grade 2
8.221600E-01
Normal-vs-Grade 3
8.401400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.822440E-02
Grade 1-vs-Grade 3
1.146090E-02
Grade 1-vs-Grade 4
7.368400E-01
Grade 2-vs-Grade 3
5.355000E-01
Grade 2-vs-Grade 4
8.221600E-01
Grade 3-vs-Grade 4
8.401400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.199400E-01
Normal-vs-NonDiabetic
1.394040E-01
Diabetic-vs-NonDiabetic
6.041600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.183000E-01
Normal-vs-NoPancreatitis
1.167770E-01
Pancreatitis-vs-NoPancreatitis
7.640300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.177570E-01
Normal-vs-N1
1.635390E-01
N0-vs-N1
8.125800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.860600E-01
Normal-vs-TP53-NonMutant
1.159950E-01
TP53-Mutant-vs-TP53-NonMutant
1.459570E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
